Biomedical Engineering Reference
In-Depth Information
References
1. Stefani M, Dobson CM (2003) Protein
aggregation and aggregate toxicity, new
insights into protein folding, misfolding dis-
eases and biological evolution. J Mol Med
81:678-699
2. Chiti F, Dobson CM (2006) Protein mis-
folding, functional amyloid, and human dis-
ease. Annu Rev Biochem 75:333-366
3. Stefani M (2004) Protein misfolding and
aggregation: new examples in medicine and
biology of the dark side of the protein world.
Biochim Biophys Acta 1739:5-25
4. Selkoe DJ (2003) Folding proteins in fatal
ways. Nature 426:900-904
5. Reilly MM (1998) Genetically determined
neuropathies. J Neurol 245:6-13
6. Kelly J (1998) Alternative conformation of
amyloidogenic proteins and their multi-step
assembly pathways. Curr Opin Struct Biol
8:101-106
7. Dobson CM (2001) The structural basis of
protein folding and its links with human dis-
ease. Phil Trans R Soc Lond B 356:133-145
8. Lambert MP, Barlow AK, Chromy BA,
Edwards C, Freed R, Liosatos M, Morgan
TE, Rozovsky I, Trommer B, Viola KL, Wals
P, Zhang C, Finch CE, Krafft GA, Klein WL
(1998) Diffusible nonfibrillar ligands derived
from Ab-42 are potent central nervous sys-
tem neurotoxins. Proc Natl Acad Sci USA
95:6448-6453
9. Walsh DM, Hartley DM, Kusumoto Y,
Fezoui Y, Condron MM, Lomakin A,
Benedek GB, Selkoe DJ, Teplow DB (1999)
Amyloid b-protein fibrillogenesis. Structure
and biological activity of protofibrillar inter-
mediates. J Biol Chem 274:25945-25952
10. Walsh DM, Klyubin I, Fadeeva JV, Cullen
WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe
DJ (2002) Naturally secreted oligomers of
amyloid b protein potently inhibit hippocam-
pal long-term potentiation in vivo. Nature
416:535-539
11. Conway KA, Lee S-J, Rochet JC, Ding TT,
Williamson RE, Lansbury PT (2000)
Acceleration of oligomerization not fibrilli-
zation is a shared property of both alpha-
synuclein mutations linked to early-onset
Parkinson's disease. Implication for patho-
genesis and therapy. Proc Natl Acad Sci USA
97:571-576
12. Reixach N, Deechingkit S, Jiang X, Kelly JW,
Buxbaum JN (2004) Tissue damage in the
amyloidoses: transthyretin monomers and
nonnative oligomers are the major cytotoxic
species in tissue culture. Proc Natl Acad Sci
USA 101:2817-2822
13. Clarke G, Collins RA, Leavitt BR, Andrews
DF, Hayden MR, Lumsden CJ, McInnes RR
(2000) A one-hit model of cell death in
inherited neuronal degeneration. Nature 406:
195-199
14. Perutz MF, Windle AH (2001) Cause of
neuronal death in neurodegenerative diseases
attributable
to
expansion
of
glutamine
repeats. Nature 412:143-144
15. Litvinovich SV, Brew SA, Aota S, Akiyama
SK, Haudenschild C, Ingham KC (1998)
Formation of amyloid-like fibrils by self-asso-
ciation of a partially unfolded fibronectin
type III module. J Mol Biol 280:245-258
16. Gujiarro JI, Sunde M, Jones JA, Campbell
ID, Dobson CM (1998) Amyloid fibril for-
mation by an SH3 domain. Proc Natl Acad
Sci USA 95:4224-4228
17. Chiti F, Webster P, Taddei N, Clark A, Stefani
M, Ramponi G, Dobson CM (1999)
Designing conditions for in vitro formation
of amyloid protofilaments and fibrils. Proc
Natl Acad Sci USA 96:3590-3594
18. Chiti F, Bucciantini M, Capanni C, Taddei
N, Dobson CM, Stefani M (2001) Solution
conditions can promote formation of either
amyloid protofilaments or mature fibrils from
the HypF N-terminal domain. Protein Sci
10:2541-2547
19. Fändrich M, Dobson CM (2002) The behav-
iour of polyamino acids reveals an inverse
side chain effect in amyloid structure forma-
tion. EMBO J 21:5682-5690
20. Dobson CM (2003) Protein folding and
misfolding. Nature 426:884-890
21. Monsellier E, Chiti F (2007) Prevention of
amyloid-like aggregation as a driving force of
protein evolution. EMBO Rep 8:737-742
22. Dobson CM (1999) Protein misfolding,
evolution and disease. Trends Biochem Sci
24:329-332
23. Chiti F, Stefani M, Taddei N, Ramponi G,
Dobson CM (2003) Rationalization of the
effects of mutations on peptide and protein
aggregation rates. Nature 424:805-808
24. Serpell LC, Sunde M, Benson MD, Tennent
GA, Pepys MB, Fraser PE (2000) The proto-
filament substructure of amyloid fibrils.
J Mol Biol 300:1033-1039
25. Jiménez JL, Nettleton EJ, Bouchard M,
Robinson CV, Dobson CM, Saibil HR
Search WWH ::
Custom Search